Management of heavy bleeding with Drakshadi Yoga and Kutajashtaka Ghana: A comparative clinical study

Management of Asrigdara with Drakshadi Yoga and Kutajashtaka Ghana with special reference to Dysfunctional Uterine Bleeding: A comparative clinical study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/09/015728

Enrollment

Registered

2018-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Kutajashataka ghana: Kutaja Salmali Patha Samanga Ativisha Musta Bilva Dhataki 500 milligrams with sheetal jala as anupana Control Intervention1: Drakshadi yoga: Draksha Sita Kutaki Ma

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of Asrigdara having any two of the following symptoms Heavy menstrual bleeding (amount >80ml) or Prolonged menstrual bleeding (With the duration of bleeding >7 days) or Inter menstrual bleeding or Frequent menstrual cycle (interval

Exclusion criteria

Exclusion criteria: Patients having bleeding due to abortion. Patients having coagulation disorders. Patients having bleeding after menopause. Any type of malignancy. Pregnant woman. Patients having STDs. Patients having any systemic diseases. Uterine and pelvic pathology like- Polyps, Endometrial TB, Fibroid, Adenomyosis, PID etc. Patients using IUCDs.

Design outcomes

Primary

Measure	Time frame
improvement in subjective and objective parametersTimepoint: improvement in subjective and objective parameters	—

Secondary

Measure	Time frame
relief in AsrigdaraTimepoint: 2 months	—

Countries

India

Contacts

Public ContactMeemansa

National Institute of Ayurveda, Jaipur

meemansaswami21@gmail.com7597639996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026